Abstract
Introduction:
Recurrent spontaneous abortion (RSA) is associated with embryonic chromosomal abnormalities, yet the maternal genetic factors predisposing to the production of aneuploid gametes remain incompletely understood. Identifying germline variants that disrupt meiotic chromosome segregation may elucidate the genetic etiology of RSA.
Methods:
Peripheral blood DNA was collected from 100 RSA patients for whom aneuploidy of embryonic origin had been confirmed in prior miscarriage specimens, and whole-exome sequencing (WES) was performed. Rare missense variants in candidate meiotic genes were identified and prioritized for functional analysis. The effect of GPSM2 loss-of-function was modeled via siRNA-mediated knockdown in germ cell lines, and meiotic progression, ploidy outcomes, and spindle-associated protein localization were assessed in vitro and in vivo.
Results:
Two patients harbored rare heterozygous missense point mutations in GPSM2 (G protein signaling modulator 2). GPSM2 knockdown resulted in a marked increase in diploid spermatocytes (NC: 10.6% vs. GPSM2-siRNA: 53.8%) and a corresponding decrease in haploid spermatids (NC: 57.8% vs. GPSM2-siRNA: 5.49%), indicating failure of the first meiotic division, while earlier spermatogenic stages remained unaffected. Mechanistically, GPSM2 was found to interact with the nuclear mitotic apparatus (NUMA) protein; upon GPSM2 depletion, chromosome separation was arrested at metaphase in GC-2 cells, and NUMA failed to localize to the spindle poles.
Discussion:
These findings suggest that rare GPSM2 missense mutations predicted to impair gene function may compromise first meiotic chromosome segregation through disruption of the GPSM2–NUMA interaction at the spindle pole, thereby predisposing carriers to produce aneuploid germ cells. Fertilization of such aneuploid gametes would yield chromosomally abnormal embryos, providing a mechanistic basis for RSA in these patients. However, definitive causal attribution awaits direct functional characterization of the specific missense variants identified, as the current study employed siRNA-mediated knockdown as a surrogate loss-of-function model.
1 Introduction
Recurrent spontaneous abortion (RSA) refers to the loss of two or more pregnancies. RSA is a gynecological complication with a high incidence that has a serious impact on the physical and mental health of women. Approximately 15% of clinically diagnosed pregnancies end in miscarriage, the majority of which occur during the first trimester. The probability of having two consecutive miscarriages is 1%–5%, and the probability of having more than three consecutive miscarriages is less than 1% (; ). The etiology of RSA includes genetic and nongenetic factors. The genetic factors are mainly chromosomal abnormalities in the products of conception (POC), which account for approximately 29%–50% of RSAs. Routine cytogenetic analysis indicates that 50% of these cases are caused by chromosomal abnormalities, such as aneuploidy ().
Whole-exome sequencing (WES) targets the protein-coding regions of DNA. The exome accounts for 1% of the human genome and is estimated to contain 85% of the gene mutations associated with disease (). Compared with whole-genome sequencing (WGS), WES is less expensive, generates smaller datasets, and is more manageable while still providing comprehensive coverage of the coding regions of DNA. WES has been widely used in clinical practice to detect genetic factors for structural anomalies, third-trimester pregnancy failure, and developmental disorders (; ; ). However, a few WES studies have reported that gene mutations may lead to RSA. KIF14 is a compound heterozygous mutation in an unexplained euploid RSA family (). Meanwhile, a homozygous ECEL1 missense mutation has caused arthrogryposis multiplex congenita and terminations in close relatives in a family (). A novel homozygous MUSK mutation was identified in an independent couple with a history of fetal akinesia and RSA (). Couples with RSA related to fetal microcephaly carry STIL compound heterozygous mutations (), and a homozygous nonsense mutation in the CEP55 gene was detected in a non-consanguineous couple with two fetuses, both with Meckel syndrome (). Couples experiencing fetal abnormalities and recurrent abortion were found to carry IFT122 heterozygous mutations (). A separate study revealed that two consanguineous Iranian couples who experienced RSA carried homozygous missense mutations in NOP14 (). Two WES studies of RSA caused by fetal edema were the first to report that men in a conventional couple with FOXP3 gene mutations caused disease in a pair of multiple pregnancy failures (). FOXP3 is an X-linked gene known to cause fetal idle syndrome (). The second novel mutation was identified in a consanguineous couple, with the autosomal recessive mutation of CHRNA1 also causing fetal anemia ().
No studies have reported that recurrent miscarriage caused by aneuploid embryos is attributed to genetic mutations in patients. The above studies did not focus on RSA caused by aneuploid embryos. Therefore, we collected peripheral blood from 100 individuals with abnormal chromosomal contributions to RSA caused by aneuploid embryos from our previously reported program () and performed WES analysis. Two patients carried rare point mutations in G protein signaling modulator 2 (GPSM2), whose pathogenicity was predicted using software. Amino acid synthesis controlled by GPSM2 was also conserved in the evolutionary sequence of each species. GPSM2 is a conserved protein that participates in the regulation of cell polarity and spindle organization during mitosis and meiosis (). During the interphase of mitosis, the GPSM2 protein is distributed in the cytoplasm and is spatially separated from the nuclear mitotic apparatus (NUMA) protein; the GPSM2 protein interacts with microtubules and plays a role in the formation and organization of the mitotic spindle during cell division. However, in the middle and late stages of mitosis, this protein colocalizes with the NUMA protein at the spindle poles. Some researchers suggest that the C-terminal of the GPSM2 protein interacts with the N-terminal of the NUMA protein to form a complex, while NUMA simultaneously associates with the dynein/dynactin motor complex. Under the guidance of the GPSM2 protein, the entire complex protein moves towards the negative end of the spindle, pulling the microtubules together to form the spindle poles, guiding the chromosomes to move towards the two poles of the cell, and completing the correct separation of the chromosomes (). The overexpression or RNA interference of GPSM2 during the first round of meiotic division in mice disrupts the spindle pole structure, leading to incorrect chromosome separation (; ). Experiments in cell and animal models have shown that GPSM2 knockdown can lead to abnormalities in the first stage of meiosis in oocytes, arrest of the first stage of meiosis in mouse spermatocytes, and metaphase arrest of chromosome separation in GC-2 cells. The pathogenesis may be caused by the inability of the NUMA protein to interact with sufficient GPSM2 protein to localize correctly at the poles of the spindle. This study indicates that, if the GPSM2 mutations lead to the impairment of the gene function, they may result in an increased rate of aneuploidy.
2 Materials and methods
2.1 Participants
Our research group previously reported the origin of incorrect chromosomes in aneuploid embryo abortion samples from 100 patients with RSA who were recruited from the Shanghai Ji Ai Genetics and IVF Institute and the Obstetrics and Gynecology Hospital of Fudan University (). The study regarding the cohorts was approved by the institutional review boards of all participating institutes, and signed informed consent was obtained from all subjects who participated in the study.
2.2 Whole-exome sequencing
Blood DNA was extracted using a TIANamp Blood DNA Kit (TIANGEN). We used 1 μg of genomic DNA to enrich the human exome using the Agilent SureSelect XT Human All Exon Kit and sequenced the DNA on the Illumina HiSeq X-TEN sequencing platform (Illumina). The raw data were mapped to the human genome assembly GRCh37/hg19 using Burrows–Wheeler Aligner (BWA) software. In this study, PCR duplicates were removed using Picard software, and the quality of mutations was assessed by obtaining valid reads, valid bases, average coverage depth, and coverage ranging from 90 to 1,203. ANNOVAR software was subsequently used for functional annotation, with information from a variety of databases and bioinformatics tools, including OMIM and the 1000 Genomes Project. Deleterious missense mutations were predicted simultaneously via SIFT and PolyPhen-2. Sanger sequencing was conducted for mutation verification using the primers listed in Supplementary Table S1. The WES data have been uploaded to the China National GenBank under project number CNP0008044.
2.3 Mouse culture
Sexually mature male and female ICR mice (over 4 weeks old) were purchased from Shanghai Jiesjie Laboratory Animal Co., Ltd. (Shanghai, China). The mice were placed in a specific pathogen-free animal room under controlled conditions (temperature, 25 °C ± 2 °C; humidity, 50%–60%; and a 12/12 h light/dark cycle). All mice were acclimated to the housing environment for at least 1 week before formal experiments were performed. For studies involving animals, the animal study protocol was approved by the Laboratory Animal Ethics Committee, School of Life Sciences, Fudan University (protocol number 2022JS071 and approval date 18 May 2022).
2.4 Seminiferous tubule injection and microinjection
ICR mice were anesthetized by intraperitoneal injection (sodium pentobarbital). On the micro-operation table, the testes of the mice were exposed to surgical scissors and tweezers, and GPSM2 siRNA (sense 5′-3′GGUCUGAGCUACAGCACAATT; antisense 5′-3′UUGUGCUGUAGCUCAGACCTT) (60 µg) or GPSM2 negative control siRNA (sense 5′-3′ UUCUCCGAACGUGUCACGUTT; antisense 5′-3′ACGUGACACGUUCGGAGAATT) (60 µg), mixed with Entranster in vivo (Engreen Biosystem, Beijing, China) solution supplemented with bromophenol blue as an indicator, was injected into the seminiferous tubules of the mice. After the operation was completed, the wounds of the mice were sutured. A total of 5–10 pL of GPSM2 negative control siRNA (1 mM; NC) or GPSM2 small interfering RNA (siRNA) (25 mM) was microinjected into the cytoplasm of the oocytes with an Eppendorf microinjector (Hamburg, Germany), with the procedure completed within 1 h. After injection, the oocytes were cultured for 24 h in M2 medium (Sigma) supplemented with milrinone (Jinpan). They were then transferred to fresh medium and cultured under mineral oil at 37 °C in an atmosphere of 5% CO2. After siRNA injection into the testicular seminiferous tubules of the mice for 14 days, we collected samples in a uniform manner for subsequent experiments.
2.5 siRNA transfection and synchronization
The cells were seeded into six-well plates 1 day earlier to maintain a cell density of 60%–80%. Afterward, 125 μL of DMEM without antibiotics or serum was added to the EP tubes, followed by 100 pmol of siRNA. The solution was gently mixed by pipetting, after which 4 μL of Lipo 8000™ (Beyotime, Shanghai, China) transfection reagent was added. The solution was mixed again and incubated at room temperature for 20 min. Drops were added to six-well plates for cellular siRNA interference. Some cells were used for qRT‒PCR (Supplementary Table S2) to determine the efficiency of GPSM2 interference. For synchronization, after 16 h of siRNA interference, the cells were cultured with 10 mM thymidine (Tsbiochem, Shanghai, China) for 16 h. Then, we released the thymidine to replace the medium, and immunofluorescence observation was performed 10 h later.
2.6 Immunofluorescence and HE staining
The sections or cell slides were subsequently washed with 1X PBS. They were fixed with 4% paraformaldehyde (Solarbio, Beijing, China) for 30 min at room temperature and then washed three times with 1X PBS for 3 min per wash. The membranes were permeabilized with Triton X-100 for 30 min at room temperature and then washed three times with PBS for 3 min each. The cells were blocked overnight at 4 °C in 3% BSA (Solarbio, Beijing, China). The primary antibody was diluted, incubated at 37 °C for 1 h, and then washed three times with 1X PBS for 5 min per wash. Similarly, the secondary antibody was diluted, incubated at 37 °C for 1 h, and then washed three times with PBS for 5 min per wash. Nuclear staining was performed with DAPI (Beyotime, Shanghai, China), and the cells were observed using a Nikon A1.
The mice were killed by cervical dislocation, and the testicular tissue was removed and cut into small pieces of 2–3 mm thickness to facilitate penetration of the fixative. The removed testicular tissue was rinsed with 1X PBS solution, then fixed with testicular tissue fixation solution (Shanghai Sibao Biotechnology Co., Ltd., Wuhan, China), and sent to Sibao Biotechnology Company (Wuhan, China) for terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL), peptide nucleic acid (PNA), and hematoxylin–eosin staining (HE).
2.7 Flow cytometry experiments
The testes were removed, precooled, and washed once with 1X PBS (Solarbio, Beijing, China). We removed the tunica albuginea of the testis and fully chopped the testicular tissue before placement into an EP tube. Type II collagenase (Life-iLab, Shanghai, China) was added to 1 mL of DMEM/F12 to a final concentration of 1.5 mg/mL, and the chopped testicular tissue was transferred at 37 °C and digested with shaking at 50 r/min for 20 min. Then, the supernatant was removed by centrifugation at 1,500 r/min for 5 min. Type II collagenase and hyaluronidase (MERCK, Kenilworth, NJ, United States) were added to 0.5% trypsin to a final concentration of 1.5 mg/mL. We added 500 µL to resuspend the cell mass, followed by digestion for 20–30 min at 37 °C with shaking at 150 r/min. Digestion was terminated by the addition of 500 µL of DMEM/F12 and centrifugation at 1,500 r/min for 5 min to remove the supernatant. We added 500 µL of PBS [containing RNase A (50 μg/mL)], followed by incubation at 37 °C for 30 min and centrifugation at 1,500 r/min for 5 min to remove the supernatant. The samples were subsequently washed once with PBS and centrifuged at 1,500 r/min for 5 min to remove the supernatant. The following working mixture of Triton X-100 + PI (Biosharp, Shanghai, China) was added: PI to a final concentration of 50 μg/mL and Triton X-100 (Sigma‒Aldrich, Saint Louis, MO, United States) to a final concentration of 0.03%, after which the cells were gently mixed and stained for 10 min at room temperature in the dark. After all treatments were completed, the mixture was filtered through a 200-mesh filter and analyzed using the instrument.
2.8 Quantification and statistical analysis
Immunofluorescence signal quantification was performed using ImageJ (version 1.52a) software. Data are shown as the mean ± s.d. For comparative analysis, an unpaired Student’s two-tailed t-test was used, and the results were graphed using GraphPad Prism 9.
2.9 Principles for screening candidate genes causing diseases
Genes with identical abnormal mutations detected in both WES analyses, present in families with more than two sporadic cases and a minor allele frequency (MAF) of less than 1%, were prioritized. Based on the literature and databases (SIFT, PolyPhen-2, and PROVEAN) for pathogenicity prediction, genes related to “aneuploidy,” “abnormal meiotic division of sperm and eggs,” “abnormal development from fertilized egg to embryo,” and other phenotypes that may cause RSA were selected. In the WES results, loss-of-function mutations such as premature termination and frameshift mutations (variable splicing changes) were prioritized. Candidate genes that have been studied during meiosis, such as FLNA and KNL1, were not included in the scope of this research. Therefore, we selected the top-ranked candidate pathogenic gene GPSM2 for our study (Supplementary Table S3).
3 Results
3.1 Two patients with RSA carried rare mutations in GPSM2
The CNV-seq results of the last abortion samples of Patient 1 and Patient 2 were “47,XX+18” and “47,XY+22,” respectively (Supplementary Figure S1). STR results revealed that the abnormal chromosomes all originated from the mother (Figure 1A) (these data have been previously reported) (). According to the STR loci on the abnormal chromosomes, the pregnancy product was compared with those of the couple, and the extra chromosomes 18 and 22 were most likely of maternal origin. They were found to carry rare monoallelic missense point mutations in the G protein signaling modulator 2 (GPSM2) gene (Supplementary Tables S3, S4). WES results for Patient 1 are provided in Data Sheet 2 (WES ID: WES-190021958), who harbors the GPSM2 variant c.1493G>A [p.Arg498Gln]. WES results for Patient 2 are provided in Data Sheet 3 (WES ID: WES-190033286), who carries the GPSM2 variant c.122G>A [p.Arg41His] (Figures 1A,B). Although the two variants are classified as “variants of uncertain significance” (VUS) according to the guidelines of the American Society of Human Genetics, the SIFT and PolyPhen-2 databases predicted that both GPSM2 point mutations are more likely to be damaging (Supplementary Table S5). The human GPSM2 gene is located on chromosome 1 and contains 15 exons, 14 of which encode proteins. The full-length transcript is 7,152 bases long and encodes 684 amino acids. Its full-length protein contains 6 TPR protein domains spanning amino acids 62–355 from the N-terminus to the C-terminus and 4 GoLoco protein domains at amino acids 489–650. WES revealed that the mutation site carried by Patient 1, GPSM2c.1493G>A, [p.Arg498Gln], is located within any known protein domain, whereas the mutation site carried by Patient 2, GPSM2c.122G>A, [p.Arg41His], is located in the GoLoco protein domain (Figure 1C). According to the conservation analysis of the GPSM2 protein and comparison of the amino acid mutation sites identified in the patients, the amino acids at both mutation sites are highly conserved across major species (Supplementary Figure S2). Analysis using the STRING database revealed that human GPSM2 interacts most strongly with INSC, whereas mouse GPSM2 protein interacts most strongly with both NUMA1 and INSC. This difference may reflect the fact that the interaction between GPSM2 and NUMA1 has thus far been reported only in mice (Supplementary Figure S3).
FIGURE 1
3.2 Knockdown of GPSM2 may induce the generation of aneuploid germ cells
Interfering with GPSM2 in mouse germinal vesicle (GV) oocytes can disrupt MI spindle organization (). The interference efficiency of GPSM2 siRNA was greater than 70% in GC-2 cells and mouse seminiferous tubules (Supplementary Figure S4). To investigate the effect of GPSM2 knockdown on chromosome separation during germ cell meiosis, we first injected siRNA into mouse GV-stage oocytes and observed their phenotype after they were cultured to the MII stage. Only approximately 23% of the oocytes in the GPSM2–siRNA group could excrete the first polar body, and approximately 80% of the GV mouse oocytes in the NC group could successfully excrete the first polar body, suggesting that knocking down the expression of GPSM2 in mouse oocytes may lead to the production of secondary oocytes with abnormal chromosome numbers; that is, aneuploid or polyploid secondary oocytes are produced (Figures 2A,B). To explore the causes of the abnormal chromosome number in spermatocytes of mouse testes after GPSM2 interference, we examined testis sections from the two groups of mice following DAPI staining. Compared with the negative control (NC) group, approximately 60% of the secondary spermatocytes in the GPSM2–siRNA group were arrested at metaphase and failed to complete the meiotic division from secondary spermatocytes to spermatids. In contrast, only approximately 20% of the secondary spermatocytes in the NC group exhibited this phenomenon; these cells may have been in the metaphase stage of the second meiotic division, with chromosomes aligned on the equatorial plate. Approximately 80% of the secondary spermatocytes in the NC group displayed chromosomes migrating toward opposite poles of the cell (Figures 2C,D). Flow cytometry revealed that the percentages of haploid (N), diploid (2N), and tetraploid (4N) cells were 5.49%, 53.8%, and 3.34%, respectively, in the GPSM2–siRNA group and 57.8%, 10.6%, and 6.93%, respectively, in the NC group. Compared with those in the NC group, the number of haploid sperm cells in the GPSM2–siRNA group was significantly lower, and the number of diploid cells was significantly greater. These findings suggest that knockdown of GPSM2 may lead to chromosome nondisjunction during metaphase in secondary spermatocytes of the mouse testis, resulting in a significant increase in the number of diploid cells, which are likely secondary spermatocytes arrested during chromosome segregation (Figures 2E,F). These results suggest that knocking down GPSM2 may interfere with chromosome separation during sperm and egg maturation, increasing the probability of germ cell development with abnormal chromosome numbers.
FIGURE 2
3.3 Interference of GPSM2 in the seminiferous tubules leads to oligoasthenozoospermia in mice
In this study, the length and width of the testis in the GPSM2–siRNA group were reduced compared with those in the NC group (Figures 3A,B). HE staining of the testes of the two groups of mice revealed that a large number of spermatocytes, spermatids, round spermatids, and elongating/elongated spermatids were missing in the GPSM2–siRNA group, and cell populations arranged from the wall of the seminiferous tubules to the center of the tubules according to spermatogony–spermatocyte–spermatid–spermatozoa were lacking. The phenotype of the NC group was consistent with that of the reported WT mouse testes. HE staining of the epididymis revealed a severe lack of mature, long-shaped sperm and round spermatids in the GPSM2–siRNA group, and the whole epididymis was very empty. The phenotype of the NC group was consistent with that of the WT mice, which was filled with a large number of mature sperm with well-developed heads and long, slender tails. PNA staining of the testes of the two groups revealed that the acrosome with sperm cells in the GPSM2–siRNA group was very rare, while the acrosome signal (green fluorescence signal) in the NC group was abundant, indicating that the acrosome-developed sperm cells were normal and abundant. TUNEL assays of testicular sections from the two groups of mice revealed no significant apoptotic events in the seminiferous tubules (Figure 3C). These results indicated that knockdown of GPSM2 significantly reduced the number of spermatocytes in the mouse testis and ultimately reduced the number of sperm in the epididymis. This decrease was not caused by spermatocyte apoptosis.
FIGURE 3
3.4 Interference with the GPSM2 gene did not affect spermatogenic events before chromosome segregation during MI in spermatocytes
In this study, several marker proteins were selected from the published literature for immunofluorescence detection in testicular paraffin-embedded sections to explore the important biological events of GPSM2 in the regulation of spermatogenesis. First, DDX4, a marker protein specific to spermatogenic cells, is commonly used to distinguish spermatogenic cells from somatic cells (). Immunofluorescence staining revealed that the majority of the spermatogenic cells in the testes of GPSM2–siRNA and NC groups were intact, especially the primary spermatocytes, as indicated by the “white arrow,” which had a large number and complete cell structure, and the spermatogonia marked by the “white asterisk” had a normal number and complete cell structure (Figures 4A,B). Interference with GPSM2 did not significantly affect the number of spermatogenic cells. Kit is a spermatogonial marker (), and little difference in the red fluorescence intensity of Kit protein labeling was detected in the seminiferous tubules of the GPSM2–siRNA and NC group mice (Figures 4A,C). These findings indicated that interference with GPSM2 expression did not significantly affect the number of cells in the spermatogonial pool. Immunofluorescence assays using Plzf (; ) and Stra8 () protein markers confirmed that knockdown of GPSM2 did not affect spermatogonial self-renewal or spermatogonial differentiation during spermatogenesis (Supplementary Figures S5A–C). Immunofluorescence assays using GFRα1 () and Sox9 () protein markers in mouse testis sections confirmed that knockdown of GPSM2 did not affect the self-differentiation of SSCs or the number of Sertoli cells (Supplementary Figures S5D–F).
FIGURE 4
To test whether the interference of GPSM2 affects homologous chromosome association events and chromosomal DNA double-strand breaks in the interphase of spermatocytes, two protein markers, Sycp3 and γH2AX, were selected for immunofluorescence staining of mouse testis paraffin sections. Sycp3 is a marker of the chromosome association complex in primary spermatocytes during interphase (). As determined by the red fluorescence signal of Sycp3 in the testis sections of the GPSM2–siRNA and NC groups, the similar intensity of fluorescence signals in the two groups and a sufficient number of labeled primary spermatocytes indicated that the interference of GPSM2 did not affect homologous chromosome association events in primary spermatocytes during interphase. γH2AX is a histone protein and a marker of chromosome breakage events (). In this study, the green fluorescence signal of γH2AX was similar between the two groups, the number of labeled spermatocytes was sufficient, and the cellular structure remained intact, indicating that GPSM2 interference did not affect chromosome breakage events during meiotic interphase in spermatocytes (Figures 4D–F).
3.5 Knocking down GPSM2 may interfere with the localization and block chromosome segregation
The N-terminal TPR domain of the GPSM2 protein binds to the NUMA–dynactin–dynein complex during mitosis, whereas the C-terminus of the GPSM2 protein binds to the Gαi protein anchored to the inner membrane of the cell. Metaphase of cell division, when chromosomes are uniformly arranged in the equatorial plate: Gαi pulls on GPSM2 to coordinate the NUMA–dynactin–dynein complex, which pulls spindle microtubules toward the cell poles. This is used to guide chromosome segregation to obtain a normal number (). Therefore, in the present study, we investigated whether GPSM2 proteins similarly bind NUMA proteins to participate in the regulation of normal chromosome segregation during meiosis. In the NC group, the GPSM2 protein was widely distributed in the spermatogonia, spermatocytes, and spermatids, whereas the α-tubulin protein fluorescence signal did not significantly change in the testicular sections of the two groups and remained normal. These findings indicated that the interference of GPSM2 did not cause serious damage to testicular tissue structure (Figure 5A). Immunofluorescence staining of NUMA protein and dynamitin, a subunit of dynactin–dynein protein complex, in testicular sections from the two groups revealed that, compared with that in the NC group, in the GPSM2–siRNA group, the green fluorescence signal of NUMA was weakened in all cell layers of spermatogonia, spermatocytes, and spermatids, indicating that GPSM2 interference may affect the normal expression of NUMA protein. The red fluorescence intensity of the dynamitin protein did not significantly differ between the two groups, indicating that GPSM2 interference did not significantly affect the localization or expression of the dynactin–dynein complex protein (Figures 5A–C).
FIGURE 5
Given that the subcellular localization of spermatocyte target proteins could not be clearly observed in mouse testicular sections, GC-2 cells were chosen as the cellular model for this study: GC-2 cells remain in a “mitotic” mode for more than 30 generations of cell division, and no genomic information was integrated and altered since only two non-mouse plasmids were transferred. The proteins involved in the completion of the so-called “mitosis” are all authentic regulatory proteins during spermatocyte meiosis. Therefore, in this study, GC-2 cells (approximately 105 cells) were treated with GPSM2–siRNA or NC–siRNA for 48 h. Immunofluorescence assays were performed on cell slides, and NUMA and α-tubulin (spindle marker proteins) were used as markers to observe the localization of regulatory proteins during chromosome segregation. In this study, we found that GC-2 cells in the GPSM2–siRNA group were arrested at metaphase, with chromosomes neatly aligned at the center of the equatorial plate and unable to move toward the poles. No colocalization signals between NUMA and α-tubulin were observed at the spindle poles. However, the GC-2 cells in the NC group had moved to the cell poles under the traction of the complex protein, and the cell membrane continued to divide. A clear colocalization signal between NUMA and α-tubulin was observed at the poles of the spindle (Figure 5D). Previous studies have reported that the GPSM2 protein can interact with the NUMA protein in vitro (). These results suggest that GPSM2 may also bind to the NUMA protein and localize to the spindle poles, guiding chromosomes aligned at the equatorial plate toward the poles and ultimately facilitating chromosome segregation with the correct chromosome number (Figure 6).
FIGURE 6
4 Discussion
Fetal aneuploidy is among the main causes of RSA (). In this study, WES of patients with RSA with an abnormal number of abortive products revealed that two female patients carried GPSM2 missense point mutations. Patients with Chudley–McCullough syndrome often carry homozygous GPSM2 mutations (; ; ), but the relationships among GPSM2 mutations, aneuploid embryos, and gametophyte formation have not been reported. Therefore, the purpose of this study was to explore the role of GPSM2 in regulating chromosome separation during sperm‒egg maturation. GPSM2 is involved not only in cell mitosis but also in the regulation of oocyte meiosis (; ; ). Therefore, using mouse spermatocytes and oocytes as models, we demonstrated that knockdown of GPSM2 can lead to abnormal chromosome segregation in mouse spermatocytes and significantly increase the number of diploid spermatogenic cells. At the poles of the spindle during the metaphase of mitosis, the N-terminal TPR domain of the GPSM2 protein binds specifically to the C-terminus of the NUMA protein, leading the NUMA protein to bind to the dynactin–dynein complex proteins to localize the stellate microtubule-associated chromosomes to the poles (). In this study, immunofluorescence staining revealed that chromosomes were arrested and failed to segregate during metaphase in GC-2 cells when GPSM2 was knocked down and that the NUMA protein could not localize to the spindle poles. Moreover, in vivo IP and in vitro pull-down assays revealed that the N-terminus of GPSM2 could bind to the C-terminus of the NUMA protein (). Therefore, the NUMA protein may form a complex with the GPSM2 protein to bind to the dynactin–dynein complex. Under the traction of the GPSM2 protein to the poles of the cell, the NUMA–dynactin–dynein complex protein guides the spindle microtubules to pull chromosomes to the poles, ensuring that the chromosomes reach the correct position and complete the chromosome separation process of meiosis (Figure 6). The pathogenic mechanism may involve the inability of the NUMA protein to interact with sufficient GPSM2 protein, resulting in its improper localization to the spindle poles.
Owing to the risk of off-target effects associated with gene-editing technology, this study did not construct an animal model that exactly replicated the missense mutation of the GPSM2 gene identified in the patients. Although siRNA-mediated interference disrupting GPSM2 function cannot fully recapitulate the effects of a point mutation, it was used to simulate the pathogenic consequences of GPSM2 loss of function on the generation of chromosomal aneuploidy in reproductive cells. Based on predictions of the harmfulness of the GPSM2 missense mutation carried by the patients using the SIFT, PolyPhen-2 and PROVEAN databases, combined with the literature reporting that GPSM2 is involved in regulating the process of mitotic chromosome segregation, we conducted a series of experimental studies on the chromosome segregation regulation process of GPSM2 during sperm and egg formation to confirm that the GPSM2 protein also plays an important role in regulating chromosome segregation during meiosis. Our research findings have provided new insights into the potential pathogenesis of gene function impairment caused by the GPSM2 missense mutation, which may increase the risk of recurrent miscarriage with aneuploidy. We have also identified potential pathogenic loci that deserve special attention. These research results also offer certain research direction guidance for reducing the clinical risk of recurrent miscarriage.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author. The WES data has been uploaded to the National Gene Bank of China (https://db.cngb.org/) under project number CNP0008044.
Ethics statement
The studies involving humans were approved by the Shanghai Ji Ai Genetic and Infertility Diagnosis and Treatment Center Assisted Reproduction Ethics Committee. The participants provided their written informed consent to participate in this study. The animal study was approved by the Experimental Animal Ethics Committee of the School of Life Sciences, Fudan University. The study was conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
KL: Conceptualization, Formal Analysis, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing. YiZ: Data curation, Formal Analysis, Funding acquisition, Investigation, Project administration, Writing – review and editing. YuZ: Formal Analysis, Investigation, Methodology, Project administration, Writing – review and editing. YL: Conceptualization, Supervision, Validation, Visualization, Writing – review and editing. HC: Conceptualization, Funding acquisition, Supervision, Validation, Visualization, Writing – review and editing. DL: Conceptualization, Data curation, Funding acquisition, Supervision, Validation, Visualization, Writing – review and editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by National Key R&D Program (2023YFC2705600 and 2023YFC2705602), the Ningbo clinical medical research center of major research project (2024L002), and the Chongqing medical scientific research project (Joint project of Chongqing Health Commission and Science and Technology Bureau, 2022MSXM086).
Acknowledgments
The authors would like to thank the patients for taking part in their research.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2026.1677758/full#supplementary-material
References
1
AndersonE. L.BaltusA. E.Roepers-GajadienH. L.HassoldT. J.de RooijD. G.van PeltA. M.et al (2008). Stra8 and its inducer, retinoic acid, regulate meiotic initiation in both spermatogenesis and oogenesis in mice. Proc. Natl. Acad. Sci. USA105, 14976–14980. 10.1073/pnas.0807297105
2
Bender AtikR.ChristiansenO. B.ElsonJ.KolteA. M.LewisS.MiddeldorpS.et al (2018). ESHRE guideline: recurrent pregnancy loss. Hum. Reprod. Open2, 2018. 10.1093/hropen/hoy004
3
BondesonM. L.EricsonK.GudmundssonS.AmeurA.PontenF.WesstromJ.et al (2017). A nonsense mutation in CEP55 defines a new locus for a meckel-like syndrome, an autosomal recessive lethal fetal ciliopathy. Clin. Genet.92, 510–516. 10.1111/cge.13012
4
BuaasF. W.KirshA. L.SharmaM.McLeanD. J.MorrisJ. L.GriswoldM. D.et al (2004). Plzf is required in adult Male germ cells for stem cell self-renewal. Nat. Genet.36, 647–652. 10.1038/ng1366
5
CarssK. J.HillmanS. C.ParthibanV.McMullanD. J.MaherE. R.KilbyM. D.et al (2014). Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum. Mol. Genet.23, 3269–3277. 10.1093/hmg/ddu038
6
ChoiM.SchollU. I.JiW.LiuT.TikhonovaI. R.ZumboP.et al (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl. Acad. Sci. USA.106, 19096–19101. 10.1073/pnas.0910672106
7
CostoyaJ. A.HobbsR. M.BarnaM.CattorettiG.ManovaK.SukhwaniM.et al (2004). Essential role of Plzf in maintenance of spermatogonial stem cells. Nat. Genet.36, 653–659. 10.1038/ng1367
8
CristofoliF.De KeersmaeckerB.De CatteL.VermeeschJ. R.Van EschH. (2017). Novel STIL compound heterozygous mutations cause severe fetal microcephaly and centriolar lengthening. Mol. Syndromol.8, 282–293. 10.1159/000479666
9
DohertyD.ChudleyA. E.CoghlanG.IshakG. E.InnesA. M.LemireE. G.et al (2012). GPSM2 mutations cause the brain malformations and hearing loss in Chudley-McCullough syndrome. Am. J. Hum. Genet.90, 1088–1093. 10.1016/j.ajhg.2012.04.008
10
DohrnN.LeV. Q.PetersenA.SkovboP.PedersenI. S.ErnstA.et al (2015). ECEL1 mutation causes fetal arthrogryposis multiplex congenita. Am. J. Med. Genet. A167a, 731–743. 10.1002/ajmg.a.37018
11
DuQ.Todd StukenbergP.MacaraI. G. (2001). A mammalian Partner of inscuteable binds NuMA and regulates mitotic spindle organization. Nat. Cell. Biol.3, 1069–1075. 10.1038/ncb1201-1069
12
FilgesI.NosovaE.BruderE.TercanliS.TownsendK.GibsonW. T.et al (2014). Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype. Clin. Genet.86, 220–228. 10.1111/cge.12301
13
GuoX.GaoS. (2009). Pins homolog LGN regulates meiotic spindle organization in mouse oocytes. Cell Res.19, 838–848. 10.1038/cr.2009.54
14
HassoldT.ChenN.FunkhouserJ.JoossT.ManuelB.MatsuuraJ.et al (1980). A cytogenetic study of 1000 spontaneous abortions. Ann. Hum. Genet.44, 151–178. 10.1111/j.1469-1809.1980.tb00955.x
15
KiyomitsuT.CheesemanI. M. (2012). Chromosome and spindle-pole-derived signals generate an intrinsic code for spindle position and orientation. Nat. Cell Biology14, 311–317. 10.1038/ncb2440
16
LarsenE. C.ChristiansenO. B.KolteA. M.MacklonN. (2013). New insights into mechanisms behind miscarriage. BMC Med.11, 154. 10.1186/1741-7015-11-154
17
LeiC.LiaoK.ZhaoY.LongZ.ZhuS.WuJ.et al (2023). A novel system for the detection of spontaneous abortio causing aneuploidy and its erroneous chromosome-origins through the combination of low-pass copy number variation sequencing and NGS-based STR tests. J. Clin. Med.12, 1809–1821. 10.3390/jcm12051809
18
NakagawaT.SharmaM.NabeshimaY.BraunR. E.YoshidaS. (2010). Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment. Science328, 62–67. 10.1126/science.1182868
19
Practice Committee of the American Society for Reproductive Medicine (2012). Multiple gestation associated with infertility therapy: an American society for reproductive medicine practice committee opinion. Fertil. Steril.97 (4), 825–834.
20
RaeW.GaoY.BunyanD.HoldenS.GilmourK.PatelS.et al (2015). A novel FOXP3 mutation causing fetal akinesia and recurrent Male miscarriages. Clin. Immunol.161, 284–285. 10.1016/j.clim.2015.09.006
21
RazE. (2000). The function and regulation of vasa-like genes in germ-cell development. Genome Biol.1, REVIEWS1017. 10.1186/gb-2000-1-3-reviews1017
22
ShamseldinH. E.SwaidA.AlkurayaF. S. (2013). Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing. Genet. Med.15, 307–309. 10.1038/gim.2012.130
23
ShamseldinH. E.KurdiW.AlmusafriF.AlnemerM.AlkaffA.BabayZ.et al (2018). Molecular autopsy in maternal-fetal medicine. Genet. Med.20, 420–427. 10.1038/gim.2017.111
24
SunS.JiangY.ZhangQ.PanH.LiX.YangL.et al (2022). Znhit1 controls meiotic initiation in male germ cells by coordinating with Stra8 to activate meiotic gene expression. Dev. Cell57, 901–913. 10.1016/j.devcel.2022.03.006
25
SuzukiT.BehnamM.RonasianF.SalehiM.ShiinaM.KoshimizuE.et al (2018). A homozygous NOP14 variant is likely to cause recurrent pregnancy loss. J. Hum. Genet.63, 425–430. 10.1038/s10038-018-0410-6
26
TsurusakiY.YonezawaR.FuruyaM.NishimuraG.PoohR. K.NakashimaM.et al (2014). Whole exome sequencing revealed biallelic IFT122 mutations in a patient with CED1 and recurrent pregnancy loss. Clin. Genet.85, 592–594. 10.1111/cge.12215
27
WalshT.ShahinH.Elkan-MillerT.LeeM. K.ThorntonA. M.RoebW.et al (2010). Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am. J. Hum. Genet.87, 90–94. 10.1016/j.ajhg.2010.05.010
28
WilbeM.EkvallS.EureniusK.EricsonK.Casar-BorotaO.KlarJ.et al (2015). MuSK:a new target for lethal fetal akinesia deformation sequence (FADS). J. Med. Genet.52, 195–202. 10.1136/jmedgenet-2014-102730
29
WrightC. F.FitzgeraldT. W.JonesW. D.ClaytonS.McRaeJ. F.van KogelenbergM.et al (2015). Genetic diagnosis of developmental disorders in the DDD study:a scalable analysis of genome-wide research data. Lancet385, 1305–1314. 10.1016/S0140-6736(14)61705-0
30
YarizK. O.WalshT.AkayH.DumanD.AkkaynakA. C.KingM.-C.et al (2012). A truncating mutation in GPSM2 is associated with recessive non-syndromic hearing loss. Clin. Genet.81, 289–293. 10.1111/j.1399-0004.2011.01654.x
31
ZhangX.GunewardenaS.WangN. (2021). Nutrient restriction synergizes with retinoic acid to induce mammalian meiotic initiation in vitro. Nat. Commun.12, 1758. 10.1038/s41467-021-22021-6
32
ZhuJ.WenW.ZhengZ.YuanS.WeiZ.XiaoZ.et al (2011). LGN/mInsc and LGN/NuMA complex structures suggest distinct functions in asymmetric cell division for the Par3/mInsc/LGN and Gai/LGN/NuMA pathways. Mol. Cell43, 418–431. 10.1016/j.molcel.2011.07.011
Summary
Keywords
aneuploidy, G protein signaling modulator 2, nuclear mitotic apparatus, recurrent spontaneous abortion, whole-exome sequencing
Citation
Liao K, Zhu Y, Zhao Y, Liu Y, Chen H and Lu D (2026) Rare variants of GPSM2 associated with aneuploidy-mediated recurrent spontaneous abortion: mechanistic insights from siRNA knockdown modeling of hypothesized loss-of-function. Front. Cell Dev. Biol. 14:1677758. doi: 10.3389/fcell.2026.1677758
Received
01 August 2025
Revised
21 May 2026
Accepted
21 May 2026
Published
17 June 2026
Volume
14 - 2026
Edited by
Senthilkumar Ramamoorthy, University of Freiburg Medical Center, Germany
Reviewed by
Yuxiang Zhang, Shanghai General Hospital, China
Digumarthi V S Sudhakar, National Animal Resource Facility for Biomedical Research (NARFBR), India
Updates
Copyright
© 2026 Liao, Zhu, Zhao, Liu, Chen and Lu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yi Liu, hsliuyi0205@163.com; Hongyan Chen, chenhy@fudan.edu.cn; Daru Lu, drlu@fudan.edu.cn
† These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.